Back
Vertex Pharmaceuticals Vs. Gilead Sciences Industry Stock Comparison
Buy
57
VRTX
Vertex Pharmaceuticals
Last Price:
$502.09
Seasonality Move:
11.16%
Buy
72
GILD
Gilead Sciences
Last Price:
$113.38
Seasonality Move:
2.19%
Buy
57
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals [VRTX] share price is $495.42. The Score for VRTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
-
The current Gilead Sciences [GILD] share price is $113.99. The Score for GILD is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
GILD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $495.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $113.99The current trend is moderately bullish and GILD is experiencing slight buying pressure.
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.39 | Buy |
Relative Strength Index (14 RSI): | 62.39 | Buy |
Chaikin Money Flow: | 1122456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (465.5 - 488.32) | Buy |
Bollinger Bands (100): | (429.84 - 488.02) | Buy |
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.78 | Buy |
Relative Strength Index (14 RSI): | 64.83 | Buy |
Chaikin Money Flow: | 1140792 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (100.11 - 114.63) | Buy |
Bollinger Bands (100): | (87.12 - 103.54) | Buy |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 487.34 | Buy |
20-day SMA: | 476.55 | Buy |
50-day SMA: | 448.95 | Buy |
200-day SMA: | 467 | Buy |
8-day EMA: | 487.35 | Buy |
20-day EMA: | 478.03 | Buy |
50-day EMA: | 464.13 | Buy |
200-day EMA: | 452.98 | Buy |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 115.29 | Sell |
20-day SMA: | 109.71 | Buy |
50-day SMA: | 100.06 | Buy |
200-day SMA: | 84.71 | Buy |
8-day EMA: | 114.31 | Sell |
20-day EMA: | 110.15 | Buy |
50-day EMA: | 102.89 | Buy |
200-day EMA: | 89.23 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $0.09 per share, an increase this year of $17.58 per share, and an increase next year of $2.24 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, a decrease next quarter of $0.15 per share, an increase this year of $3.54 per share, and an increase next year of $0.39 per share.
Vertex Pharmaceuticals Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gilead Sciences Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |